Edit: I note previous chats with IR around potential margins etc...

Edit: I note previous chats with IR around potential margins etc and was indicated. I found the commentary around this for everyone's own interpretation: In terms of margins on sales, I believe that Lumos will not be paid any kind of royalty but will make money from a manufacturing margin for supplying the finished product that is sold. Worth noting, when a device is approved, it includes the place of manufacture so there is a real switching barrier which is why these medical device manufacturing contracts are so valuable - effectively annuity income. I would guess (and this is a guess) that would be around 15-20% of the wholesale price which is typically 60% of the retail price. So if you worked off 7.5%-10% of sales, you should be in the ballpark. But this is a guess (educated guess but still a guess).

So at this stage, if the total FFN sales from the perinatal reported revenue was even 50% of the total revenue recorded last year, and we ran off the lower figure of 7.5%, then it could be around $4.5-$5M annually.

Who knows what the actual figure of sales is until the first annual reporting of revenues received and whether someone makes it clearer.